Balance Sheet Sartorius AG

Equities

SRT3

DE0007165631

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 11:36:55 2026-04-10 am EDT			5-day change	1st Jan Change
214.40 ^EUR	-0.09%		+0.94%	-13.27%

Apr. 10	SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating	ZD
Apr. 10	JPMorgan Maintains Overweight Rating on Sartorius with 295 Euro Price Target	DP

e6e0b6d0691f4ef0f29665fde.WOdQfGxBtjGF4U3rXwlAHES3qA8NxcHOjXrJUVgaXe8.EIs8Tisp33TPhX_dZ0JweDXg90VbsZ6Nug6CNztNa6U21GcyMzjQV_yWHA

Published financial data: SARTORIUS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.45B	4.17B	3.4B	3.38B	3.54B
Total Revenues	3.45B	4.17B	3.4B	3.38B	3.54B
Cost of Goods Sold, Total	1.61B	1.98B	1.83B	1.86B	1.9B
Gross Profit	1.84B	2.2B	1.57B	1.52B	1.64B
Selling General & Admin Expenses, Total	746M	830M	851M	886M	899M
R&D Expenses	140M	178M	171M	197M	173M
Other Operating Expenses	19.99M	13.4M	4.3M	6.4M	-3M
Other Operating Expenses, Total	906M	1.02B	1.03B	1.09B	1.07B
Operating Income	933M	1.18B	541M	435M	568M
Interest Expense, Total	-26.57M	-34.5M	-143M	-182M	-172M
Interest And Investment Income	396K	1M	4.6M	22.1M	13.9M
Net Interest Expenses	-26.17M	-33.5M	-138M	-160M	-158M
Income (Loss) On Equity Invest.	-	-	-6.5M	-8.6M	-3.3M
Currency Exchange Gains (Loss)	10.54M	-51M	-16.4M	1.4M	-15.1M
Other Non Operating Income (Expenses)	4.08M	2.5M	-20.8M	-23.6M	-26.1M
EBT, Excl. Unusual Items	921M	1.09B	359M	244M	365M
Merger & Related Restructuring Charges	-	-	-12M	-	-
Gain (Loss) On Sale Of Investments	-	-	-20M	-11M	-6.4M
Asset Writedown	-	-	-	-	-700K
Other Unusual Items	-253M	88.2M	58.7M	-46.6M	-21M
EBT, Incl. Unusual Items	668M	1.18B	386M	187M	337M
Income Tax Expense	241M	269M	95.9M	49.4M	106M
Earnings From Continuing Operations	427M	913M	290M	137M	230M
Net Income to Company	427M	913M	290M	137M	230M
Minority Interest	-108M	-235M	-84.9M	-53.4M	-75.5M
Net Income - (IS)	319M	678M	205M	84M	155M
Net Income to Common Incl Extra Items	319M	678M	205M	84M	155M
Net Income to Common Excl. Extra Items	319M	678M	205M	84M	155M
Per Share Items
Net EPS - Basic	4.66	9.91	3	1.22	2.24
Basic EPS - Continuing Operations	4.66	9.91	3	1.22	2.24
Basic Weighted Average Shares Outstanding	68.42M	68.42M	68.42M	68.98M	69.05M
Net EPS - Diluted	4.66	9.91	3	1.22	2.24
Diluted EPS - Continuing Operations	4.66	9.91	3	1.22	2.24
Diluted Weighted Average Shares Outstanding	68.42M	68.42M	68.42M	68.98M	69.05M
Normalized Basic EPS	6.84	6.55	2.04	1.44	2.21
Normalized Diluted EPS	6.84	6.55	2.04	1.44	2.21
Dividend Per Share	1.25	1.44	0.74	0.74	0.74
Payout Ratio	15.13	12.67	47.86	60.36	32.73
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	1.11B	1.4B	811M	730M	886M
EBITA	1.03B	1.29B	687M	586M	729M
EBIT	933M	1.18B	541M	435M	568M
EBITDAR	1.12B	1.41B	821M	737M	891M
Effective Tax Rate - (Ratio)	36.12	22.73	24.84	26.45	31.61
Total Current Taxes	261M	278M	101M	84.5M	125M
Total Deferred Taxes	-19.42M	-9.5M	-5.1M	-35.1M	-18.4M
Normalized Net Income	468M	448M	140M	99.35M	153M
Interest Capitalized	-	-	-	17.9M	14.7M
Interest on Long-Term Debt	3.06M	3.8M	5.3M	6.1M	7.9M
Non-Cash Pension Expense	312K	600K	1.6M	1.8M	1.7M
Supplemental Operating Expense Items
Selling and Marketing Expenses	581M	628M	634M	669M	666M
General and Administrative Expenses	165M	200M	214M	215M	231M
Research And Development Expense From Footnotes	165M	212M	173M	216M	174M
Net Rental Expense, Total	9.73M	11.8M	9.9M	6.8M	4.7M
Imputed Operating Lease Interest Expense	993K	1.41M	2.88M	2.2M	1.59M
Imputed Operating Lease Depreciation	8.74M	10.39M	7.02M	4.6M	3.11M
Stock-Based Comp., Other (Total)	2.96M	1M	600K	1.8M	3.8M
Total Stock-Based Compensation	2.96M	1M	600K	1.8M	3.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	343M	166M	379M	813M	541M
Short Term Investments	18.18M	30.9M	15M	15.3M	10.4M
Total Cash And Short Term Investments	361M	197M	394M	829M	552M
Accounts Receivable, Total	424M	484M	351M	318M	238M
Other Receivables	28.95M	30.8M	60.5M	62.5M	50.3M
Notes Receivable	5.25M	8.4M	14.6M	10.8M	2.9M
Total Receivables	458M	524M	426M	391M	292M
Inventory	893M	1.18B	1.04B	788M	792M
Other Current Assets, Total	84.79M	124M	100M	105M	130M
Total Current Assets	1.8B	2.02B	1.96B	2.11B	1.77B
Gross Property Plant And Equipment	1.51B	1.81B	2.18B	2.52B	2.88B
Accumulated Depreciation	-525M	-617M	-754M	-895M	-1.02B
Net Property Plant And Equipment	986M	1.19B	1.42B	1.62B	1.86B
Long-term Investments	60.85M	151M	115M	82.1M	67.9M
Goodwill	1.36B	1.72B	3.42B	3.5B	3.47B
Other Intangibles, Total	933M	1.07B	1.81B	1.63B	1.45B
Deferred Tax Assets Long-Term	75.15M	83.6M	83.9M	86.3M	123M
Deferred Charges Long-Term	162M	212M	292M	334M	374M
Other Long-Term Assets, Total	322M	527M	663M	731M	607M
Total Assets	5.7B	6.98B	9.76B	10.1B	9.72B
Liabilities
Accounts Payable, Total	283M	305M	306M	344M	343M
Accrued Expenses, Total	208M	166M	146M	174M	196M
Current Portion of Long-Term Debt	311M	524M	255M	356M	891M
Current Portion of Leases	26.14M	31.2M	33.2M	36.6M	35.4M
Current Income Taxes Payable	179M	222M	198M	144M	93.8M
Unearned Revenue Current, Total	306M	324M	278M	254M	202M
Other Current Liabilities	234M	232M	113M	136M	206M
Total Current Liabilities	1.55B	1.8B	1.33B	1.44B	1.97B
Long-Term Debt	1.65B	1.87B	4.91B	4.02B	3.18B
Long-Term Leases	88.91M	112M	114M	145M	172M
Pension & Other Post Retirement Benefits	81.73M	64.3M	64.1M	69.4M	67M
Deferred Tax Liability Non Current	182M	235M	453M	405M	432M
Other Non Current Liabilities	429M	230M	128M	119M	27.2M
Total Liabilities	3.98B	4.32B	7B	6.21B	5.85B
Common Stock, Total	68.42M	68.4M	68.4M	69M	69.1M
Retained Earnings	1.17B	1.86B	1.97B	2.39B	2.49B
Comprehensive Income and Other	25.86M	65.2M	26.9M	309M	146M
Total Common Equity	1.26B	1.99B	2.07B	2.76B	2.71B
Minority Interest	460M	669M	690M	1.13B	1.16B
Total Equity	1.72B	2.66B	2.76B	3.9B	3.87B
Total Liabilities And Equity	5.7B	6.98B	9.76B	10.1B	9.72B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	68.42M	68.42M	68.42M	69.04M	69.05M
ECS Total Common Shares Outstanding	68.42M	68.42M	68.42M	69.04M	69.05M
Book Value / Share	18.42	29.08	30.22	40.05	39.2
Tangible Book Value	-1.03B	-800M	-3.16B	-2.37B	-2.22B
Tangible Book Value Per Share	-15.13	-11.69	-46.12	-34.31	-32.09
Total Debt	2.08B	2.54B	5.31B	4.56B	4.28B
Net Debt	1.71B	2.34B	4.92B	3.73B	3.73B
Debt Equivalent of Unfunded Proj. Benefit Obligation	75.4M	57.5M	56.5M	59.6M	57M
Debt Equivalent Oper. Leases	77.83M	94.4M	79.2M	54.4M	37.6M
Minority Interest, Total (Incl. Fin. Div)	460M	669M	690M	1.13B	1.16B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	307M	455M	374M	262M	245M
Inventories - Work In Process, Total	211M	240M	244M	184M	168M
Inventories - Finished Goods, Total	356M	466M	409M	334M	372M
Inventories - Others	18.75M	18.3M	9.7M	8.3M	7.4M
Land - (BS)	722M	836M	1.04B	1.22B	1.44B
Machinery, Total	616M	746M	872M	999M	1.1B
Full Time Employees	13.83K	15.94K	13.93K	12.83K	13.3K
Part Time Employees	-	-	687	702	743
Accumulated Allowance for Doubtful Accounts (Supple)	15.54M	15.6M	17.3M	16M	16.5M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	319M	678M	205M	84M	155M
Depreciation & Amortization - CF	105M	136M	162M	183M	196M
Amortization of Goodwill and Intangible Assets - (CF)	101M	117M	146M	151M	161M
Depreciation & Amortization, Total	206M	253M	308M	334M	357M
Amortization of Deferred Charges, Total - (CF)	25.22M	33.8M	30M	62.5M	62.3M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	20M	11M	6.4M
Asset Writedown & Restructuring Costs	-	-	4.5M	19.3M	700K
(Income) Loss On Equity Investments - (CF)	-	-	6.5M	8.6M	3.3M
Other Operating Activities, Total	398M	158M	136M	179M	248M
Change In Accounts Receivable	-99.14M	-86.6M	169M	27.3M	45.8M
Change In Inventories	-294M	-262M	118M	259M	-48.6M
Change in Other Net Operating Assets	311M	-41.3M	-143M	-8.4M	6.9M
Cash from Operations	866M	734M	854M	976M	837M
Capital Expenditure	-407M	-523M	-560M	-410M	-442M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-142M	-536M	-2.24B	-	-67.1M
Investment in Marketable and Equity Securities, Total	-	-	-	-15.9M	-4.7M
Other Investing Activities, Total	-20.77M	-71.2M	-22.7M	-	-
Cash from Investing	-570M	-1.13B	-2.82B	-426M	-514M
Long-Term Debt Issued, Total	137M	1.65B	6.06B	12.6M	8.7M
Total Debt Issued	137M	1.65B	6.06B	12.6M	8.7M
Long-Term Debt Repaid, Total	-212M	-1.24B	-3.56B	-848M	-348M
Total Debt Repaid	-212M	-1.24B	-3.56B	-848M	-348M
Issuance of Common Stock	-	-	-	198M	-
Common Dividends Paid	-48.23M	-85.9M	-98.2M	-50.7M	-50.7M
Common & Preferred Stock Dividends Paid	-48.23M	-85.9M	-98.2M	-50.7M	-50.7M
Other Financing Activities, Total	-42.24M	-109M	-230M	559M	-201M
Cash from Financing	-165M	210M	2.17B	-128M	-591M
Foreign Exchange Rate Adjustments	8.01M	8.9M	17.3M	12M	-3.9M
Miscellaneous Cash Flow Adjustments	343K	-	-	100K	-
Net Change in Cash	139M	-177M	213M	434M	-272M
Supplemental Items
Cash Interest Paid	31.51M	35.2M	108M	210M	181M
Cash Income Tax Paid (Refund)	189M	239M	155M	145M	161M
Levered Free Cash Flow	483M	127M	85M	434M	289M
Unlevered Free Cash Flow	500M	148M	174M	547M	396M
Change In Net Working Capital	-89.94M	352M	-57.3M	-287M	-60.1M
Net Debt Issued / Repaid	-74.71M	405M	2.49B	-835M	-340M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.45	11.59	4.04	2.74	3.58
Return on Total Capital	16.06	16.33	5.1	3.29	4.27
Return On Equity %	27.54	41.7	10.71	4.13	5.93
Return on Common Equity	27.83	41.73	10.12	3.48	5.66
Margin Analysis
Gross Profit Margin %	53.31	52.61	46.15	45.09	46.26
SG&A Margin	21.63	19.87	25.06	26.22	25.41
EBITDA Margin %	32.28	33.47	23.89	21.6	25.04
EBITA Margin %	29.97	30.96	20.23	17.33	20.59
EBIT Margin %	27.05	28.16	15.93	12.86	16.04
Income From Continuing Operations Margin %	12.38	21.87	8.54	4.06	6.51
Net Income Margin %	9.25	16.24	6.04	2.48	4.38
Net Avail. For Common Margin %	9.25	16.24	6.04	2.48	4.38
Normalized Net Income Margin	13.56	10.74	4.11	2.94	4.31
Levered Free Cash Flow Margin	14.02	3.04	2.5	12.83	8.16
Unlevered Free Cash Flow Margin	14.5	3.55	5.13	16.19	11.2
Asset Turnover
Asset Turnover	0.68	0.66	0.41	0.34	0.36
Fixed Assets Turnover	3.85	3.83	2.6	2.22	2.03
Receivables Turnover (Average Receivables)	9.34	9.19	8.13	10.11	12.72
Inventory Turnover (Average Inventory)	2.22	1.91	1.65	2.03	2.41
Short Term Liquidity
Current Ratio	1.16	1.12	1.47	1.46	0.9
Quick Ratio	0.53	0.39	0.61	0.84	0.43
Operating Cash Flow to Current Liabilities	0.56	0.41	0.64	0.68	0.43
Days Sales Outstanding (Average Receivables)	39.06	39.72	44.88	36.19	28.7
Days Outstanding Inventory (Average Inventory)	164.35	191.13	221.14	179.93	151.73
Average Days Payable Outstanding	44.34	47.37	66.16	74.04	65.83
Cash Conversion Cycle (Average Days)	159.06	183.48	199.86	142.08	114.59
Long Term Solvency
Total Debt/Equity	120.65	95.58	192.62	116.98	110.74
Total Debt / Total Capital	54.68	48.87	65.83	53.91	52.55
LT Debt/Equity	101.03	74.7	182.18	106.9	86.78
Long-Term Debt / Total Capital	45.79	38.2	62.26	49.27	41.18
Total Liabilities / Total Assets	69.81	61.9	71.73	61.42	60.2
EBIT / Interest Expense	35.12	34.07	3.79	2.39	3.3
EBITDA / Interest Expense	42.87	41.41	5.95	4.23	5.38
(EBITDA - Capex) / Interest Expense	27.54	26.27	2.03	1.98	2.81
Total Debt / EBITDA	1.82	1.78	6.26	5.93	4.63
Net Debt / EBITDA	1.51	1.64	5.79	4.85	4.03
Total Debt / (EBITDA - Capex)	2.84	2.8	18.37	12.7	8.87
Net Debt / (EBITDA - Capex)	2.34	2.59	17.01	10.4	7.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	47.68	21.03	-18.66	-0.44	4.66
Gross Profit, 1 Yr. Growth %	52.43	19.44	-28.65	-2.76	7.37
EBITDA, 1 Yr. Growth %	72.12	25.5	-41.93	-9.96	18.21
EBITA, 1 Yr. Growth %	77.73	25.02	-46.85	-14.69	20.39
EBIT, 1 Yr. Growth %	82.68	26	-53.97	-19.75	25.02
Earnings From Cont. Operations, 1 Yr. Growth %	42.54	113.84	-68.23	-52.72	67.69
Net Income, 1 Yr. Growth %	51.78	112.64	-69.74	-59.14	84.4
Normalized Net Income, 1 Yr. Growth %	143.24	-4.13	-68.84	-29.04	36.99
Diluted EPS Before Extra, 1 Yr. Growth %	51.78	112.64	-69.74	-59.48	84.22
Accounts Receivable, 1 Yr. Growth %	34.92	14.27	-27.64	-9.33	-24.98
Inventory, 1 Yr. Growth %	60.21	32.07	-12.08	-23.94	0.47
Net Property, Plant and Equip., 1 Yr. Growth %	22.68	20.88	19.34	14.05	14.49
Total Assets, 1 Yr. Growth %	27.05	22.46	39.81	3.67	-3.82
Tangible Book Value, 1 Yr. Growth %	-2.15	-22.74	294.63	-24.71	-6.47
Common Equity, 1 Yr. Growth %	22.19	57.88	3.9	33.71	-2.1
Cash From Operations, 1 Yr. Growth %	69.26	-15.92	16.26	14.36	-14.26
Capital Expenditures, 1 Yr. Growth %	69.47	28.34	7.1	-26.76	7.81
Levered Free Cash Flow, 1 Yr. Growth %	100.19	-73.79	-32.89	412.64	-35.27
Unlevered Free Cash Flow, 1 Yr. Growth %	96.06	-70.35	17.47	215.02	-29.19
Dividend Per Share, 1 Yr. Growth %	78.57	14.29	-48.61	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.4	33.69	-0.78	-10.01	2.08
Gross Profit, 2 Yr. CAGR %	39.79	34.93	-7.69	-16.69	2.18
EBITDA, 2 Yr. CAGR %	53.33	46.97	-14.64	-27.7	4.52
EBITA, 2 Yr. CAGR %	57.1	49.06	-18.49	-32.66	3
EBIT, 2 Yr. CAGR %	60.52	51.71	-23.85	-39.19	2.36
Earnings From Cont. Operations, 2 Yr. CAGR %	39.76	74.59	-17.57	-61.21	-10.96
Net Income, 2 Yr. CAGR %	42.66	79.65	-19.78	-64.8	-13.2
Normalized Net Income, 2 Yr. CAGR %	79.46	52.7	-45.36	-52.92	4.41
Diluted EPS Before Extra, 2 Yr. CAGR %	42.63	79.65	-19.78	-64.95	-13.6
Accounts Receivable, 2 Yr. CAGR %	18.35	24.17	-9.07	-19	-17.52
Inventory, 2 Yr. CAGR %	47.09	45.46	7.76	-18.22	-12.58
Net Property, Plant and Equip., 2 Yr. CAGR %	16.75	21.78	20.11	16.66	14.27
Total Assets, 2 Yr. CAGR %	40.94	24.73	30.85	20.33	-0.15
Tangible Book Value, 2 Yr. CAGR %	126.1	-13.05	74.62	72.13	-16.08
Common Equity, 2 Yr. CAGR %	24.71	38.89	28.08	17.88	14.42
Cash From Operations, 2 Yr. CAGR %	51.51	19.8	-1.13	15.31	-0.98
Capital Expenditures, 2 Yr. CAGR %	34.35	47.49	17.24	-11.44	-11.14
Levered Free Cash Flow, 2 Yr. CAGR %	92.14	-27.56	-58.07	85.08	84.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	88.9	-23.75	-40.99	92.17	50.99
Dividend Per Share, 2 Yr. CAGR %	88.98	43.43	-23.36	-28.31	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	30.11	31.71	13.29	-0.67	-5.37
Gross Profit, 3 Yr. CAGR %	31.78	32.65	9.11	-6.06	-9.34
EBITDA, 3 Yr. CAGR %	40.15	43.42	7.84	-13.11	-14.08
EBITA, 3 Yr. CAGR %	42.69	45.58	5.7	-17.24	-17.39
EBIT, 3 Yr. CAGR %	46.05	48.07	1.94	-22.47	-21.55
Earnings From Cont. Operations, 3 Yr. CAGR %	29.31	61.05	-1.06	-31.47	-36.81
Net Income, 3 Yr. CAGR %	31.16	62.96	-0.78	-35.9	-38.87
Normalized Net Income, 3 Yr. CAGR %	60.06	45.61	-10.12	-40.34	-30.17
Diluted EPS Before Extra, 3 Yr. CAGR %	31.14	62.94	-0.78	-36.07	-39.06
Accounts Receivable, 3 Yr. CAGR %	11.32	16.97	3.71	-9.15	-21.04
Inventory, 3 Yr. CAGR %	40.53	41.9	22.99	-4.06	-12.42
Net Property, Plant and Equip., 3 Yr. CAGR %	33.82	18.11	20.96	18.05	15.93
Total Assets, 3 Yr. CAGR %	31.13	34.49	29.57	21.04	11.67
Tangible Book Value, 3 Yr. CAGR %	64.16	58.07	43.96	31.79	40.46
Common Equity, 3 Yr. CAGR %	19.39	34.91	26.08	29.94	10.8
Cash From Operations, 3 Yr. CAGR %	52.42	24.86	18.61	3.79	4.46
Capital Expenditures, 3 Yr. CAGR %	20.42	32.32	32.56	0.22	-5.44
Levered Free Cash Flow, 3 Yr. CAGR %	302.35	-1.09	-29.39	-3.54	31.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	216.38	1.9	-11.94	3.06	38.78
Dividend Per Share, 3 Yr. CAGR %	27.02	60.24	1.87	-16.26	-19.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.54	24.34	16.74	13.1	8.66
Gross Profit, 5 Yr. CAGR %	23.82	25.45	14.29	10.13	6.29
EBITDA, 5 Yr. CAGR %	29.04	31.84	14.94	9.05	6.5
EBITA, 5 Yr. CAGR %	30.31	33.22	14.06	6.94	4.61
EBIT, 5 Yr. CAGR %	30.51	35.03	12.55	3.72	2.13
Earnings From Cont. Operations, 5 Yr. CAGR %	24.11	41.79	8	-8.87	-5.11
Net Income, 5 Yr. CAGR %	25.38	42.67	7.74	-11.72	-5.91
Normalized Net Income, 5 Yr. CAGR %	34.9	34.12	4.13	-7.32	-4.52
Diluted EPS Before Extra, 5 Yr. CAGR %	25.37	42.66	7.73	-11.87	-6.09
Accounts Receivable, 5 Yr. CAGR %	11.94	11.42	2.67	0.98	-5.37
Inventory, 5 Yr. CAGR %	32.07	36.8	26.37	13.83	7.29
Net Property, Plant and Equip., 5 Yr. CAGR %	23.98	25.36	28.16	17.53	18.24
Total Assets, 5 Yr. CAGR %	26.59	24.88	31.02	28.63	16.72
Tangible Book Value, 5 Yr. CAGR %	56.63	14.88	68.27	63.55	15.94
Common Equity, 5 Yr. CAGR %	16.8	26.35	22.79	27.82	21.28
Cash From Operations, 5 Yr. CAGR %	38.41	28.88	28.41	20.95	10.35
Capital Expenditures, 5 Yr. CAGR %	22.31	21.53	19.14	12.69	12.96
Levered Free Cash Flow, 5 Yr. CAGR %	149.31	23.86	62.85	27.07	3.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	395.15	23.37	61.62	31.33	9.21
Dividend Per Share, 5 Yr. CAGR %	22.67	23.56	3.94	16.15	1.12